BioCentury
ARTICLE | Company News

Lexicon and Abgenix in second discovery alliance

January 3, 2001 8:00 AM UTC

The companies will use LEXG's mammalian assays to validate drug targets for human antibody production by ABGX. ABGX will have access to LEXG's OmniBank library of knockout mouse clones. LEXG will rece...